Hints and tips:
Related Special Reports
...Tenser attends Seoul Fashion Week regularly and has brought Korean labels such as We11done, LVIR and Andersson Bell to Browns....
...However, Ugur Sahin, head of BioNTech, who developed the vaccine now produced by Pfizer, struck a more positive note....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...I’d be a lot more comfortable if we were closer to 70 per cent by June 21,” said Bell....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...There were more cases of Bell’s palsy, a muscular weakness in the face, and appendicitis in the group of people who received the vaccine than the group that received the placebo....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...“The porcine grunting of hippos,” he writes, “is a sleep therapy that I swear is more effective than any crashing waves or New-Age tinkling bells”....
...Interim data have shown that its vaccine has an efficacy rate up there with the shots developed by BioNTech/Pfizer and Moderna, based on revolutionary messengerRNA technology....
...With titles ranging from BBC presenter Carrie Gracie’s Equal, about her battle for equal pay, to Creativity, Inc, by Ed Catmull, ex-chief executive of animation company Pixar, there will be something for...
...Uber, the $60bn labour-law arbitrage business, reported its second-quarter results after the bell Thursday....
...Shares in Novavax had already risen more than 1,600 per cent so far this year before the agreement was announced on Tuesday, before the US stock market’s opening bell....
...Anyway, there’s much to enjoy in the paper for policy wonks, technologists or historians, so do have a read if you want a break from wondering whether we’ll have a V-shaped recovery or not....
...They also revived a lawsuit against ice-cream maker Blue Bell’s corporate board over a listeria scandal....
...You Don’t Own Me: How Mattel v....
...John Bell, Regius professor of medicine at Oxford, who was commissioned by government to develop the life sciences strategy, said a number of large companies, including Roche, Novartis and Pfizer had cut...
...Snap, which reports earnings after the bell, is down in LA, while further south are Broadcom, in Orange County, and Qualcomm, dominating the city of San Diego....
...Before the bell, Pfizer is set to report better-than-expected fourth-quarter results and investors will look for updates on the drugmaker’s plan to sell its multi-billion dollar consumer healthcare business...
...Evan Spiegel gazed out over the floor of the New York Stock Exchange, where onlookers were recording him with his company’s retro-cool, video-enabled sunglasses, then rang the opening bell on Snap’s first...
...Change the vertical axis label to “unhappiness” and you have the old “bell curve of discontent” oft-cited by psychologists....
...Pharma giants Pfizer and Merck reveal their earnings, in addition to Facebook, the biggest social network....
...Including Pfizer’s early talks to buy drugmaker Allergan, which could cost more than $125bn, October could beat the all-time record of $530bn worth of deals hit in June....
...The energy sector was down 1.2 per cent, while Ford and UPS fell but Pfizer rose after unveiling quarterly results....
...Much more recently, the V-22 Osprey tilt-rotor military aircraft has had a big share of problems and cost over-runs but the programme, undertaken jointly with Boeing, has been a good platform for Bell’s...
International Edition